A Study to Evaluate the Safety and Efficacy of CCX140-B in Subjects With Diabetic Nephropathy

Status:
Completed

Trial end date:
2014-12-01

Target enrollment:

Participant gender:

The purpose of this study is to evaluate the safety and efficacy of treatment with CCX140-B in subjects with diabetic nephropathy.

Phase 2

ChemoCentryx